Skip to main content

Get the latest public health information from CDC

Clinical Info HIV.gov logo
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinical info.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Guidance for Covid-19 and People with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Mobile Application

Mobile App Information 
The Clinical Info mobile application gives access to federally approved treatment and research information for HIV and AIDS, optimized for mobile devices free of charge.

Download the beta version of the Clinical Info App for your iOS or Android device.




 

Clinical Info mobile app icon

Download ClinicalInfo Guidelines app on the AppStore
Download ClinicalInfo Guidelines app on GooglePlay

Hepatitis B Virus/HIV Coinfection

  • Read more about Hepatitis B Virus/HIV Coinfection

Women with HIV

  • Read more about Women with HIV

Transgender People with HIV

  • Read more about Transgender People with HIV

Substance Use Disorders and HIV

  • Read more about Substance Use Disorders and HIV

HIV and the Older Person

  • Read more about HIV and the Older Person

HIV-2 Infection

  • Read more about HIV-2 Infection

Adolescents and Young Adults with HIV

  • Read more about Adolescents and Young Adults with HIV

Early (Acute and Recent) HIV Infection

  • Read more about Early (Acute and Recent) HIV Infection

Discontinuation or Interruption of Antiretroviral Therapy

  • Read more about Discontinuation or Interruption of Antiretroviral Therapy

Optimizing Antiretroviral Therapy in the Setting of Virologic Suppression

  • Read more about Optimizing Antiretroviral Therapy in the Setting of Virologic Suppression

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Current page 15
  • Page 16
  • Next page Next ›
  • Last page Last »

Connect with us

Facebook
Twitter
Instagram
Email Updates

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.